TheraAgent: Self-Improving Therapeutic Agent for Precise and Comprehensive Treatment Planning
Formulating a treatment plan is inherently a complex reasoning and refinement task rather than a simple generation problem. However, existing large language models (LLMs) mainly rely on one-shot output without explicit verification, which may result in rough, incomplete, and potentially unsafe treatment plans. To address these limitations, we propose TheraAgent, an agentic framework that replaces one-shot generation with an iterative generate-judge-refine pipeline. By mirroring the actual reasoning process of human experts who iteratively revise treatment plans, our framework progressively transforms coarse and incomplete drafts into precise, comprehensive, and safer therapeutic regimens. To facilitate the critical judge component, we introduce TheraJudge, a treatment-specific evaluation module integrated into the inference loop to enforce clinical standards. Experiments show TheraAgent achieves state-of-the-art results on HealthBench, leading in Accuracy and Completeness. In expert evaluations, it attains an 86% win rate against physicians, with superior Targeting and Harm Control. Moreover, the highly agreement between TheraJudge and HealthBench evaluations confirms the reliability of our framework.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Training Therapeutic Judges and Multi-Agent Systems for Human-Aligned Mental Health Support
Large language models show promise for mental health support, yet therapeutic quality improves only when evaluation functions as an actionable control signal rather than a passive metric. We introduce a framework that fo…
Response GenerationTheraAgent: Multi-Agent Framework with Self-Evolving Memory and Evidence-Calibrated Reasoning for PET Theranostics
PET theranostics is transforming precision oncology, yet treatment response varies substantially; many patients receiving 177Lu-PSMA radioligand therapy (RLT) for metastatic castration-resistant prostate cancer (mCRPC) f…
Medical DiagnosisA PBN-RL-XAI Framework for Discovering a "Hit-and-Run" Therapeutic Strategy in Melanoma
Innate resistance to anti-PD-1 immunotherapy remains a major clinical challenge in metastatic melanoma, with the underlying molecular networks being poorly understood. To address this, we constructed a dynamic Probabilis…
Reinforcement LearningPharmAgents: Building a Virtual Pharma with Large Language Model Agents
The discovery of novel small molecule drugs remains a critical scientific challenge with far-reaching implications for treating diseases and advancing human health. Traditional drug development--especially for small mole…
Drug DiscoveryLanguage ModelingLanguage ModellingLarge Language ModelTxGemma: Efficient and Agentic LLMs for Therapeutics
Therapeutic development is a costly and high-risk endeavor that is often plagued by high failure rates. To address this, we introduce TxGemma, a suite of efficient, generalist large language models (LLMs) capable of ther…
Humanity's Last ExamProperty Prediction